Drugs Made In America Acq... (DMII)
NasdaqGM: DMII
· リアルタイム株価 · USD
10.13
+0.00 (0.00%)
終値時点: Aug 12, 2026, 1:20 PM
事業内容
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
Drugs Made In America Acquisition II Corp.

| 国 | United States |
| IPO日 | 2025年12月3日 |
| 業種 | Shell Companies |
| セクター | Financial Services |
| 従業員数 | n/a |
| CEO | Mr. Roger Bendelac |
連絡先
住所: 420 Lexington Avenue New York, NY United States | |
| ウェブサイト | n/a |
銘柄情報
| ティッカー | DMII |
| 取引所 | NasdaqGM |
| 決算期 | Jan '25 - Dec '25 |
| 報告通貨 | USD |
| CIKコード | 0002040475 |
| CUSIP番号 | n/a |
| ISIN番号 | n/a |
| 雇用者番号 | n/a |
| SICコード | n/a |
主な役員
| 氏名 | 役職 |
|---|---|
| Mr. Roger Bendelac | Chief Executive Officer |
| Mr. Saleem Elmasri CPA | CFO & Principal Accounting Officer |
